TGH-2 Inhibitors

Chemical inhibitors of TGH-2 operate through various mechanisms to impede the protein's enzymatic function. Orlistat, a well-known lipase inhibitor, directly binds to the serine residue within TGH-2's active site, thus obstructing the hydrolysis of dietary fats by the enzyme. This interaction is characterized by the formation of a covalent bond between Orlistat and the serine, rendering TGH-2 unable to interact with its natural substrates. Similarly, Ebelactone A and Ebelactone B target the same active site serine residue, but these inhibitors accomplish the blockage through irreversible modification, which ensures a sustained inhibition of TGH-2's esterase activity. The chemical Methyl arachidonyl fluorophosphonate also shares this inhibition strategy by covalently modifying the active serine residue, leading to a loss of enzymatic activity.

Another compound, Palmostatin B, inhibits TGH-2 by a slightly different method, which involves the occupation of the enzyme's substrate pocket. This occupation prevents the natural lipid substrates from accessing the active site, thus inhibiting the usual lipid hydrolysis process catalyzed by TGH-2. JZL184, although primarily an inhibitor of monoacylglycerol lipase, can extend its inhibitory effects to TGH-2 by binding to the active site in a similar fashion, thereby precluding substrate binding and subsequent lipid breakdown. The same principle applies to URB602 and WWL70, both of which are known to inhibit enzymes within the serine hydrolase family by active site occupation. PF-04457845, though highly selective for fatty acid amide hydrolase, can inhibit TGH-2 by a comparable mechanism that involves the prevention of substrate processing at the active site. KT182, another irreversible inhibitor of serine hydrolases, ensures TGH-2 inhibition by modifying the crucial serine residue, leading to an enduring suppression of the enzyme's activity. SA-47 and THL (Tetrahydrolipstatin), which is another name for Orlistat, further exemplify this mode of inhibition by binding to the active site of TGH-2 and thereby halting its lipase activity.